BF-RhodoLED
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BF-RhodoLED, covering 2025-04-29 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults [Phase 2]